Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

MLA

Jorsal, Anders, et al. “Serum Adiponectin Predicts All-Cause Mortality and End Stage Renal Disease in Patients with Type I Diabetes and Diabetic Nephropathy.” Kidney International, vol. 74, no. 5, Sept. 2008, pp. 649–54. EBSCOhost, https://doi.org/10.1038/ki.2008.201.

APA

Jorsal, A., Tarnow, L., Frystyk, J., Lajer, M., Flyvbjerg, A., Parving, H.-H., Vionnet, N., & Rossing, P. (2008). Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney International, 74(5), 649–654. https://doi.org/10.1038/ki.2008.201

Chicago

Jorsal, Anders, Lise Tarnow, Jan Frystyk, Maria Lajer, Allan Flyvbjerg, Hans-Henrik Parving, Nathalie Vionnet, and Peter Rossing. 2008. “Serum Adiponectin Predicts All-Cause Mortality and End Stage Renal Disease in Patients with Type I Diabetes and Diabetic Nephropathy.” Kidney International 74 (5): 649–54. doi:10.1038/ki.2008.201.